Jeremy Cogan Sells 1,879 Shares of Movano (NASDAQ:MOVE) Stock

Movano Inc. (NASDAQ:MOVE) CFO Jeremy Cogan sold 1,879 shares of the business’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $8.35, for a total transaction of $15,689.65. Following the sale, the chief financial officer directly owned 23,325 shares of the company’s stock, valued at $194,763.75. This represents a 7.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Jeremy Cogan also recently made the following trade(s):

• On Tuesday, January 6th, Jeremy Cogan sold 8,218 shares of Movano stock. The stock was sold at an average price of $7.79, for a total value of $64,018.22.

Movano Trading Up 1.1%

Shares of Movano stock opened at $7.05 on Wednesday. The company has a fifty day moving average price of $8.86 and a 200 day moving average price of $7.57. The stock has a market cap of $5.85 million, a price-to-earnings ratio of -0.65 and a beta of 0.79. Movano Inc. has a twelve month low of $4.67 and a twelve month high of $58.76.

Movano (NASDAQ:MOVE) last released its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The firm had revenue of $0.08 million for the quarter, compared to the consensus estimate of $3.88 million.

Institutional Investors Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano as of its most recent SEC filing. 16.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on MOVE shares. Wall Street Zen upgraded Movano to a “hold” rating in a research report on Saturday, December 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Movano has a consensus rating of “Sell”.

Key Headlines Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional buying: Citadel Advisors reported a new stake (~49,262 shares, ~5.94% of the company) in Movano, which can provide demand/support for the stock and signal outside interest from a large quant manager. MarketBeat: Movano institutional holdings
• Neutral Sentiment: Short-interest picture improving but data glitched: reported short interest fell to 43,438 shares as of Dec. 31 (~5.8% of float, 0.5 days to cover), which reduces near‑term short‑squeeze risk. However a Jan. 12 report showing 0 shares appears to be a reporting error — treat January short‑interest prints cautiously. (No direct company action.)
• Negative Sentiment: Insider selling — CFO Jeremy Cogan disclosed sales: 1,879 shares (Jan. 5 at $8.35) and 8,218 shares (Jan. 6 at $7.79), materially trimming his stake. Insider sales at current low liquidity can be interpreted negatively by the market. SEC filing: Jeremy Cogan insider sales
• Negative Sentiment: More insider selling — CTO Michael Aaron Leabman sold multiple tranches (Jan. 7–9) totaling several thousand shares at ~ $7.26–$7.34, trimming his holdings. Multiple insider sales in close succession weigh on sentiment for a micro‑cap with low free float. SEC filing: Michael Aaron Leabman insider sales
• Negative Sentiment: Weak near‑term fundamentals: latest quarterly results (Nov. 14) showed a large EPS loss but a modest beat; revenue was essentially negligible (~$0.08M vs. est. ~$3.9M). Low revenue and deep negative margins increase execution and dilution risk, which matters more for a very small market‑cap company. MarketBeat: Movano earnings summary

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.